They are approved for the treatment of atopic dermatitis but not for hand eczema of other causes. Although there is only a small amount of short-term trial evidence available for tacrolimus 0·1% ...

Current treatments for chronic hand eczema (CHE) generally fall into two buckets: Either they battle inflammation but lead to ...

The US Food and Drug Administration (FDA) has approved Organon’s Vtama (tapinarof) cream, 1% to treat atopic dermatitis in ...

A new study shows that nearly 90% of patients with moderate-to-severe atopic dermatitis (AD) reported their condition negatively affected their sexual well-being, but treatment with advanced therapies ...

The global hand eczema treatment market is projected to experience robust growth, with a market value of USD 53 million in ...

In the era of artificial intelligence (AI), various trends have been observed that utilize AI in multiple sectors, having a ...

The US Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...

Adam Christman, DVM, MBA spoke with Andrew Rosenberg, DVM, DACVD about how Zenrelia is a JAK inhibitor designed to disrupt cytokine signaling pathways that trigger itch and inflammation related to ...

Crisaborole two percent ointment is a non-steroidal anti-inflammatory medication approved for treating mild-to-moderate atopic dermatitis in patients as young as three months old in countries like the ...

Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and atopic dermatitis and react to the availability of a novel JAK inhibitor.